These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 5318921)

  • 21. Psychiatric diagnosis and a typology of clinical drug effects.
    Klein DF
    Psychopharmacologia; 1968; 13(5):359-86. PubMed ID: 4884170
    [No Abstract]   [Full Text] [Related]  

  • 22. [Double-blind study of the antidepressive drugs (noxiptilin-imipramine)].
    Berner P; Guss H; Hofmann G; Kryspin-Exner K; Küfferle B
    Arzneimittelforschung; 1971 May; 21(5):638-40. PubMed ID: 4936793
    [No Abstract]   [Full Text] [Related]  

  • 23. A model for drug use with depressed patients.
    Raskin A; Boothe H; Schulterbrandt JG; Reatig N; Odle D
    J Nerv Ment Dis; 1973 Feb; 156(2):130-42. PubMed ID: 4570135
    [No Abstract]   [Full Text] [Related]  

  • 24. Affective disease health maintenance organization. Patterns of lithium response.
    Shelley EM; Mendlewicz J; Fieve RR
    N Y State J Med; 1974 Sep; 74(10):1766-8. PubMed ID: 4606182
    [No Abstract]   [Full Text] [Related]  

  • 25. Oxypertine in combination with imipramine: a controlled trial.
    Sim M; Gordon EB; Nicol CG
    J Int Med Res; 1978; 6(1):4-10. PubMed ID: 23973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mode of action and relative value of imipramine and similar drugs in the treatment of nocturnal enuresis.
    Petersen KE; Andersen OO; Hansen T
    Eur J Clin Pharmacol; 1974; 7(3):187-94. PubMed ID: 4604781
    [No Abstract]   [Full Text] [Related]  

  • 27. Chlorpromazine-procyclidine and imipramine: effects on thyroid function in psychiatric patients.
    Blumberg AG; Klein DF
    Clin Pharmacol Ther; 1969; 10(3):350-4. PubMed ID: 5795803
    [No Abstract]   [Full Text] [Related]  

  • 28. A controlled study of single-dose administration of imipramine pamoate in endogenous depression.
    Miller WC; Marcotte DB; McCurdy L
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):700-6. PubMed ID: 4201314
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative evaluation of the antidepressive properties of opipramol, imipramine and placebo in neurotic depression].
    Tétreault L; Doucet P; Blanchet A; Bordeleau JM
    Union Med Can; 1966 May; 95(5):546-53. PubMed ID: 5326793
    [No Abstract]   [Full Text] [Related]  

  • 30. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder.
    Stark P; Hardison CD
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):53-8. PubMed ID: 3882682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double-blind comparative evaluation of the efficacy and safety of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
    Merideth CH; Feighner JP; Hendrickson G
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):73-7. PubMed ID: 6370981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lithium salts in the management of the manic-depressive syndrome.
    Gershon S
    Annu Rev Med; 1972; 23():439-52. PubMed ID: 4566490
    [No Abstract]   [Full Text] [Related]  

  • 33. A statistical review of controlled trials of imipramine and placebo in the treatment of depressive illnesses.
    Rogers SC; Clay PM
    Br J Psychiatry; 1975 Dec; 127():599-603. PubMed ID: 1104034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trazodone, a triazolopyridine derivative, in primary depressive disorder.
    Feighner JP
    J Clin Psychiatry; 1980 Jul; 41(7):250-5. PubMed ID: 6993447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Action of substances protective against ulcers due to constraint in rats maintained at ambiant temperature of 14 degrees C].
    Buchel L; Gallaire D; Lévy J
    C R Seances Soc Biol Fil; 1967; 161(12):2438-40. PubMed ID: 4235659
    [No Abstract]   [Full Text] [Related]  

  • 36. Initial response to drugs in depressive illness and psychiatric and community adjustment a year later.
    Raskin A; Boothe H; Reatig N; Schulterbrandt JG
    Psychol Med; 1978 Feb; 8(1):71-9. PubMed ID: 345314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depressive illness in a general practice. A demographic study and a controlled trial of imipramine.
    Porter AM
    Br Med J; 1970 Mar; 1(5699):773-8. PubMed ID: 4910188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction between some anticholinergic agents and phenothiazines. Potentiation of phenothiazine sedation and its antagonism.
    Gershon S; Neubauer H; Sundland DM
    Clin Pharmacol Ther; 1965; 6(6):749-56. PubMed ID: 4378954
    [No Abstract]   [Full Text] [Related]  

  • 39. Chlorpromazine-placebo, chlorpromazine-chlordiazepoxide, and chlorpromazine-imipramine treatment of acutely ill patients: symptoms and symptom patterns.
    Michaux MH; Kurland AA; Vander Zwaag L
    Psychopharmacol Bull; 1967 Dec; 4(3):22-8. PubMed ID: 5615553
    [No Abstract]   [Full Text] [Related]  

  • 40. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
    Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
    J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.